Power your in vivo studies with antibodies engineered for reliability, consistency, and biological impact.
InnoCyto’s In Vivo Star™ Antibodies are purpose-built for functional animal studies, enabling confident modulation of immune pathways, cell depletion, checkpoint targeting, and receptor signaling. Each recombinant antibody is produced and validated with stringent quality controls to support reproducible experimental outcomes in demanding in vivo or in vitro environments.
Whether your research focuses on immuno-oncology, inflammation, or immune regulation, In Vivo Star™ Antibodies deliver the performance you need to translate experimental design into actionable biological insight.
Explore Products
InnoCyto's In Vivo Star™ Antibody products are purpose-built for five key preclinical and translational research applications.
In Immune Cell Depletion studies, these antibodies are used to selectively eliminate specific immune cell populations in vivo, enabling researchers to dissect the functional contributions of individual cell types to immune responses. For Immune Checkpoint Modulation, they serve as tools to block or activate checkpoint pathways (such as PD-1/PD-L1 or CTLA-4 axes), helping scientists evaluate immune regulation and inform cancer immunotherapy strategies. In Cytokine Signaling Studies, the antibodies are employed to neutralize or target cytokine pathways, allowing precise interrogation of inflammatory and immune signaling cascades in living animal models. Their use in Tumor Immunology Models supports the study of tumor-immune interactions, including immune evasion mechanisms and the efficacy of immunotherapeutic interventions in oncology research. Finally, in Autoimmune and Inflammatory Research, these antibodies help model and probe the pathological immune activation underlying autoimmune diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease, providing critical insight for therapeutic target validation. Collectively, InnoCyto's In Vivo Star Antibodies offer a versatile, high-quality reagent platform spanning the breadth of modern immunological and oncological research.